Covered recipient · General Payments record
SAHAR MCALLEN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$2,206.79
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.68 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $185.19 | 7 |
| OptiNose US, Inc. | $184.66 | 3 |
| Otsuka America Pharmaceutical, Inc. | $18.19 | 1 |
| Kowa Pharmaceuticals America, Inc. | $17.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $17.64 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113473885 | CMS |
| Novo Nordisk Inc | $5.59 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329948 | CMS |
| Novo Nordisk Inc | $124.99 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100600605 | CMS |
| Novo Nordisk Inc | $8.35 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100367235 | CMS |
| Novo Nordisk Inc | $6.60 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100647181 | CMS |
| Novo Nordisk Inc | $7.70 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100613685 | CMS |
| Novo Nordisk Inc | $7.08 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100474672 | CMS |
| Novo Nordisk Inc | $24.88 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100297939 | CMS |
| Optinose US, Inc. | $24.35 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142171024 | CMS |
| Optinose US, Inc. | $134.23 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142171016 | CMS |
| Optinose US, Inc. | $26.08 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142171028 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.19 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119132766 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.